Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1996-07-12
1999-05-25
Woodward, Michael P.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
53038824, 435335, 435336, C07K 1624, C12N 506
Patent
active
059070331
ABSTRACT:
The present invention relates to monoclonal antibodies that define Oncostatin M, a novel cytokine. The monoclonal antibodies of the invention are capable of binding to Oncostatin M, inhibiting Oncostatin M receptor binding, and/or inhibiting Oncostatin M bioactivity. Such antibodies may be used to detect the presence at Oncostatin M and/or to modulate Oncostatin M bioactivities in an in vivo or in vitro system.
REFERENCES:
Benjamin et al., 1984, "The Antigenic Structure of Proteins: A Reappraisal", Ann. Rev. Immunol. 2:67-101.
Boscato and Stuart, 1988, "Heterophilic Antibodies: A Problem for All Immunoassays", Clin. Chem. 34: 27-33.
Brown et al., 1987, "Purification and Characterization of Cytostatic Lymphokines Produced by Activated Human T Lymphocytes", J. Immunol. 139:2977-2983 (Brown I).
Brown et al., 1988, "Oncostatin M Differentially Regulates the Action of Type I Transforming Growth Factor-.beta.", J. Cell. Biochem. Suppl. 0 (12 Part A):194 (Brown II).
Brown et al., 1989, "Oncostatin M as a Unique Modulator of Endothelial Cell Surface Properties", J. Cell. Biochem. Suppl. 0 (13 Part E):189 (Brown III).
Brown et al., 1990, Molecular Biology of the Cardiovascular System, Proceedings of a UCLA Symposium held at Keystone, Co on Apr. 10-17, 1989, Roberts et al., ed., Alan R. Liss, Inc., NY, pp. 195-206 (Brown IV).
Cebrian et al., 1987, "Different Functional Sites on RIFN-o2 and their Relation to the Cellular Receptor Binding Site", J. Immunol. 138:484-490.
Cunningham and Wells, 1989, "High-Resolution Epitope Mapping of hGH-Receptor Interactions by Alanine-Scanning Mutagenesis", Science 244:1081-1085.
Gaulton and Greene, 1986, "Idiotypic Mimicry of Biological Receptors", Ann. Rev. Immunol. 4:253-280.
Gunderson et al., 1988, "Expression of Oncostatin M and Properties of the Recombinant Protein", J. Cell. Biochem. Suppl. 0 (12 Part A):224.
Harris and Emery, 1993, "Therapeutic Antibodies -the Coming of Age", TIBTECH 11:42-44.
Kadin et al., 1982, Antibody as a Tool, Marchalonis et al., eds., John Wiley & Sons NY, pp. 447-484.
Kato et al., 1979,"Use of Antibody Fab' Fragments to Remove Interference by Rhuematoid Factors with the Enzyme-Linked Sandwich Immunoassay", FEBS Lett. 102:253-256.
Linsley et al., 1988, "Identification of a Membrane Receptor for the Growth Regulator, Oncostatin M", J. Cell. Biochem. Suppl. 0 (12 Part A):227 (Linsley I).
Linsley et al., 1989, "Identification and Characterization of Cellular Receptors for the Growth Regulator, Oncostatin M", J. Biol. Chem. 264:4282-4289.
Linsley et al., 1990, "Cleavage of a Hydrophilic C-Terminal Domain Increases Growth-Inhibitory Activity of Oncostatin M", Mol. Cell. Biol. 10:1882-1890 (Linsley II).
Malik et al., 1989, "Molecular Cloning, Sequence Analysis, and Functional Expression of a Novel Growth Regulator, Oncostatin M", Mol. Cell. Biol. 9:2847-2853.
Porter, 1991, "The Prospects for Therapy with Tumor Necrosis Factors and their Antagonists", TIBTECH 9:158-162.
Redlich and Grossberg, 1989, "Analysis of Antigenic Domains on Natural and Recombinant Human IFN-y by the Inhibition of Biologic Activities with Monoclonal Antibodies", J. Immunol. 143:1887-1893.
Schreiber et al., 1980, "Anti-Alprenolol Anti-Idiotypic Antibodies Bind to .beta.-Adrenergic Receptors and Modulate Catecholamine-Sensitive Adenylate Cyclase", Proc. Natl. Acad. Sci. USA 77:7385-7389.
Sege and Peterson, 1978, "Use of Anti-Idiotypic Antibodies as Cell-Surface Receptor Probes", Proc. Natl. Acad. Sci. USA 75:2443-2447.
Vaux et al., 1990, "Identification by Anti-Idiotypic Antibodies of an Intracellular Membrane Protein that Recognizes a Mammalian Endoplasmic Reticulum Retention Signal", Nature 345:495-502.
Zarling et al., 1986, "Oncostatin M: A Growth Regulator Produced by Differentiated Histiocytic Lymphoma Cells", Proc. Natl. Acad. Sci. USA 83:9739-9743.
Linsley Peter S.
Radka Susan F.
Shoyab Mohammed
Bristol-Myers Squibb Co.
Woodward Michael P.
LandOfFree
Anti-oncostatin M monoclonal antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-oncostatin M monoclonal antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-oncostatin M monoclonal antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-401701